The estimated Net Worth of Michael P. Cooke is at least 823 千$ dollars as of 2 December 2019. Michael Cooke owns over 7,500 units of Magenta Therapeutics Inc stock worth over 168,366$ and over the last 6 years Michael sold MGTA stock worth over 654,350$.
Michael has made over 10 trades of the Magenta Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Michael sold 7,500 units of MGTA stock worth 97,500$ on 2 December 2019.
The largest trade Michael's ever made was selling 7,500 units of Magenta Therapeutics Inc stock on 2 December 2019 worth over 97,500$. On average, Michael trades about 4,375 units every 14 days since 2018. As of 2 December 2019 Michael still owns at least 240,523 units of Magenta Therapeutics Inc stock.
You can see the complete history of Michael Cooke stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is 50 Hampshire St, Cambridge, MA 02139, USA.
Over the last 6 years, insiders at Magenta Therapeutics Inc have traded over 6,775,591$ worth of Magenta Therapeutics Inc stock and bought 1,257,000 units worth 10,105,000$ . The most active insiders traders include Bruce Booth、Rock Ventures Iv, L.P.Third...、Jeffrey W. Albers. On average, Magenta Therapeutics Inc executives and independent directors trade stock every 46 days with the average trade being worth of 99,614$. The most recent stock trade was executed by Rock Ventures Iv, L.P.Third... on 7 February 2023, trading 3,700,000 units of MGTA stock currently worth 3,071,000$.
magenta therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. by creating a platform focused on key areas of transplant medicine, magenta therapeutics is pioneering an integrated, but modular approach to stem cell therapies that reboot the blood and immune systems to create patient benefit. founded by internationally recognized leaders in stem cell transplant medicine, magenta therapeutics was launched in 2016 by third rock ventures and atlas venture and is headquartered in cambridge, mass. for more information, please visit www.magentatx.com.
Magenta Therapeutics Inc executives and other stock owners filed with the SEC include: